Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pacific 8 Ventures is a venture capital firm based in the United States, focusing on seed-stage investments in healthcare technology. The firm aims to be the first institutional investor in its portfolio companies, which currently includes 10 notable startups. Their investment strategy emphasizes disruptive innovations in therapeutics, diagnostics, and health services.
This firm invests in seed-stage companies that are developing disruptive technology platforms in healthcare, biotech, and AI. Pacific 8 Ventures primarily targets the U.S. market, seeking to support innovations that enhance therapeutics, diagnostics, and health services.
Notable portfolio companies include Mammoth Biosciences, which develops in-vivo gene editing therapeutics using CRISPR technology; Certainly Health, a healthcare marketplace for insured patients; and Elsa Fertility, which aims to make reproductive care more accessible. Other companies include Hill Research, Empirical Health, Laguna Bio, Matrisome Bio, BillionToOne, MultiplyLabs, and Fauna Bio.
Submit your pitch through their form at pac8.com.
Yes, Pacific 8 Ventures often leads seed rounds, positioning itself as the first institutional investor in its portfolio companies.
The firm typically focuses on seed-stage investments but may consider follow-on investments depending on the growth and needs of their portfolio companies.
Specific fund size details are not disclosed, but the firm actively builds its portfolio with a focus on seed-stage investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.